Clinical Trial Update: A Two-Week Study of Clinical Safety and Saliva Flow Quantification [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating safety and saliva flow quantification in healthy volunteers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• Johnson & Johnson Consumer Inc. (J&JCI) study sponsor

Snippet

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI) | Conditions: Healthy | Phase 4 | Status: COMPLETED